approval
saveELREXFIO (ELRANATAMAB) — FDA approval
community read0 votes
Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- phase 3 completionCellCarta Biosciences Inc — elranatamab (Phase III Trial Completion)Apr 27, 2026 · 164d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalMar 25, 2026 · 197d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalFeb 19, 2026 · 231d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 10, 2025 · 455d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 8, 2025 · 457d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalSep 10, 2024 · 758d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalAug 14, 2023 · 1151d ago
same company · ±60 days · 4
- approvalMEDROL: MEDROL (METHYLPREDNISOLONE) — FDA approvalDec 19, 2023
- approvalMETHYLPREDNISOLONE ACETATE: DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalDec 20, 2023
- approvalIXIFI: IXIFI (INFLIXIMAB-QBTX) — FDA approvalDec 26, 2023
- approvalIDARUBICIN HYDROCHLORIDE: IDARUBICIN HYDROCHLORIDE — FDA approvalNov 6, 2023
comments(0)
5-min edit window · permanent after that